Researchers at the University of Sharjah are exploring a promising approach that could enhance the immune system's ability to fight cancer, potentially paving the way for new treatments. In a recent ...

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar ...

Immune checkpoint inhibition has emerged as a transformative strategy in the treatment of haematologic malignancies, harnessing the body’s own immune system to recognise and eliminate malignant cells.

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

Researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have identified a previously unknown mechanism by which a particularly aggressive form of colon cancer ...

Zhong-Yin Zhang leads a team that has developed and validated a novel series of small-molecule inhibitors that promote ...

ACI-19764 is an orally available highly brain-penetrant small molecule NLRP3 inhibitor NLRP3 inhibitors are a major new class of compounds linked to a broad spectrum of inflammatory conditions ...

Cancer immunotherapy has historically focused on harnessing the ability of T cells to recognize and attack cancer cells. Adaptive immune checkpoint inhibitors (ICIs) unleash tumor-infiltrating ...

AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764ACI-19764 is an orally available inhibitor of the NLRP3 ...

Researchers have developed and validated a number of small-molecule anti-cancer agents. A new PTPN22 inhibitor, L-32, reduced ...

AC Immune SA, a clinical-stage biopharmaceutical company developing targeted therapeutics for neurodegenerative diseases, has announced positive interim results from a Phase 1 study of ACI-19764 – its ...